Pro Vise Management Group, LLC Bristol Myers Squibb CO Transaction History
Pro Vise Management Group, LLC
- $1.14 Billion
- Q4 2024
A detailed history of Pro Vise Management Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pro Vise Management Group, LLC holds 5,284 shares of BMY stock, worth $271,280. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,284
Previous 7,965
33.66%
Holding current value
$271,280
Previous $412,000
27.67%
% of portfolio
0.03%
Previous 0.03%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,775Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.75 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.15 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.93 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.88 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.1 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $109B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...